Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 15.05%
March 31, 2026 4.64%
December 31, 2025 -2.92%
September 30, 2025 8.88%
June 30, 2025 3.79%
March 31, 2025 5.61%
December 31, 2024 11.95%
September 30, 2024 8.18%
June 30, 2024 -2.86%
March 31, 2024 -27.14%
December 31, 2023 -2.71%
September 30, 2023 -26.54%
June 30, 2023 -37.82%
Date Value
March 31, 2023 -35.55%
December 31, 2022 -59.46%
September 30, 2022 -58.96%
June 30, 2022 -31.63%
March 31, 2022 -46.25%
December 31, 2021 -49.65%
September 30, 2021 -19.00%
June 30, 2021 -29.00%
March 31, 2021 -41.36%
December 31, 2020 -60.25%
September 30, 2020 -26.01%
June 30, 2020 -61.28%
March 31, 2020 -65.39%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 35.34%
Repligen Corp. 49.25%
Bio-Techne Corp. 65.22%
Codexis, Inc. 68.42%
MetaStat, Inc. --

Gross Profit Margin (Quarterly) Related Metrics